Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 2/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 12/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6635088 | 0.93 | CTRB1 (0.51) | CTRB1ELANECYP3A4 | |
| SCHEMBL6638083 | 0.91 | CTRB1 (0.52) | CTRB1ELANECYP3A4POLBPKM | |
| SCHEMBL6633862 | 0.89 | CTRB1 (0.51) | CTRB1ELANECYP3A4KMT2A | |
| SCHEMBL6639087 | 0.87 | CTRB1 (0.49) | CTRB1ELANECYP3A4PKMKMT2A | |
| SCHEMBL6634778 | 0.87 | CTRB1 (0.52) | CTRB1ELANECYP3A4POLBPKM | |
| SCHEMBL6639323 | 0.84 | CTRB1 (0.49) | CTRB1ELANECYP3A4KMT2A | |
| SCHEMBL6638087 | 0.83 | CYP3A4 (0.47) | CTRB1ELANECYP3A4POLBKMT2A | |
| SCHEMBL6636916 | 0.81 | CTRB1 (0.50) | CTRB1ELANECYP3A4PKMKMT2A | |
| SCHEMBL6637518 | 0.81 | CTRB1 (0.53) | CTRB1ELANECYP3A4POLBKMT2A | |
| SCHEMBL6635224 | 0.81 | CTRB1 (0.59) | CTRB1ELANECYP3A4POLBPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |